133 related articles for article (PubMed ID: 6789856)
1. Binding of peanut lectin to germinal-centre cells: a marker for B-cell subsets of follicular lymphoma?
Rose ML; Habeshaw JA; Kennedy R; Sloane J; Wiltshaw E; Davies AJ
Br J Cancer; 1981 Jul; 44(1):68-74. PubMed ID: 6789856
[TBL] [Abstract][Full Text] [Related]
2. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
3. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
4. Peanut lectin binding properties of germinal centres of mouse lymphoid tissue.
Rose ML; Birbeck MS; Wallis VJ; Forrester JA; Davies AJ
Nature; 1980 Mar; 284(5754):364-6. PubMed ID: 7360273
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
6. Binding of peanut lectin to thymic cortex and germinal centres of lymphoid tissue.
Rose ML; Malchiodi F
Immunology; 1981 Apr; 42(4):583-91. PubMed ID: 6972347
[TBL] [Abstract][Full Text] [Related]
7. Complement receptor subtypes C3b and C3d in lymphatic tissue and follicular lymphoma.
Stein H; Siemssen U; Lennert K
Br J Cancer; 1978 Apr; 37(4):520-9. PubMed ID: 646924
[TBL] [Abstract][Full Text] [Related]
8. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
9. B- and T-cell subsets in follicular centroblastic/centrocytic (cleaved follicular center cell) lymphoma: an immunohistologic analysis of 26 lymph nodes and three spleens.
Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
Hum Pathol; 1985 Apr; 16(4):339-52. PubMed ID: 2579888
[TBL] [Abstract][Full Text] [Related]
10. Lectin histochemistry of malignant tumors. I. Peanut agglutinin (PNA) receptors in follicular lymphoma and follicular hyperplasia: an immunohistochemical study.
Ree HJ; Hsu SM
Cancer; 1983 May; 51(9):1631-8. PubMed ID: 6339030
[TBL] [Abstract][Full Text] [Related]
11. Studies of lectin binding to normal and neoplastic lymph nodes. II. Non-Hodgkin's lymphoma.
Bramwell VH; Crowther D; Gallagher J; Stoddart RW
Br J Cancer; 1982 Oct; 46(4):582-92. PubMed ID: 6182897
[TBL] [Abstract][Full Text] [Related]
12. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
13. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
[TBL] [Abstract][Full Text] [Related]
14. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
Forbes IJ; Zalewski PD; Valente L; Gee D
Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
[TBL] [Abstract][Full Text] [Related]
15. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
Harris NL; Nadler LM; Bhan AK
Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
[TBL] [Abstract][Full Text] [Related]
16. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.
Swerdlow SH; Habeshaw JA; Murray LJ; Dhaliwal HS; Lister TA; Stansfeld AG
Am J Pathol; 1983 Nov; 113(2):181-97. PubMed ID: 6416075
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte markers in non-Hodgkin's lymphomas.
Payne SV; Smith JL; Jones DB; Wright DH
Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
[TBL] [Abstract][Full Text] [Related]
19. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas.
Williamson JM; Grigor I; Smith ME; Holgate CS; Quirke P; Bird CC; Alison DL; Child JA
J Pathol; 1986 Sep; 150(1):51-9. PubMed ID: 3491205
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
